Manatuck Hill Partners’s AngioDynamics ANGO Stock Holding History

Manatuck Hill Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.6M	Sell	276,500 -198,500	-42%	-$2.26M	1.19%	29
2026 Q1	$5.4M	Buy	475,000 +50,000	+12%	+$542K	1.46%	20
2025 Q4	$5.46M	Buy	425,000 +25,000	+6%	+$309K	1.91%	18
2025 Q3	$4.47M	Buy	400,000 +50,000	+14%	+$483K	1.48%	22
2025 Q2	$3.47M	Buy	350,000 +25,000	+8%	+$245K	1.31%	24
2025 Q1	$3.05M	Buy	325,000 +125,500	+63%	+$1.32M	1.41%	27
2024 Q4	$1.83M	Buy	199,500 +124,500	+166%	+$915K	0.75%	38
2024 Q3	$584K	Buy	75,000 +25,000	+50%	+$181K	0.21%	101
2024 Q2	$303K	Buy	+50,000	New	+$309K	0.13%	101

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manatuck Hill Partners's ANGO Position: Q2 2026 in Review

Manatuck Hill Partners reduced its AngioDynamics (ANGO) stake by 42% in Q2 2026, selling an estimated $2.26M and leaving 276,500 shares worth $3.6M. The position accounts for 1.19% of the portfolio, ranked #29.

Manatuck Hill Partners first reported a position in ANGO in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.46M in Q4 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Manatuck Hill Partners held 276,500 shares of AngioDynamics worth $3.6M as of Q2 2026.
Manatuck Hill Partners sold 198,500 AngioDynamics shares in Q2 2026, an estimated $2.26M.
AngioDynamics made up 1.19% of Manatuck Hill Partners's portfolio in Q2 2026, its #29 holding.
Manatuck Hill Partners first reported a position in AngioDynamics in Q2 2024 and has held it in 9 quarters since.
Manatuck Hill Partners's AngioDynamics position peaked at $5.46M in Q4 2025.
162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Manatuck Hill Partners's 13F filing for Q2 2026, filed 14 Aug 2026.